Abstract
THE GTPase Racl is a key component in the reorganization of the actin cytoskeleton that is induced by growth factors or oncogenic Ras1. Here we investigate the role of Racl in cell transformation and show that Ratl fibroblasts expressing activated Val-12 Racl (Racl with valine at residue 12) display all the hallmarks of malignant transformation. In a focus-forming assay in NIH3T3 fibroblasts to measure the efficiency of transformation, we found that dominant-negative Asn-17 Racl inhibited focus formation by oncogenic Ras, but not by RafCAAX, a Raf kinase targeted to the plasma membrane by virtue of the addition of a car boxy-terminal localization signal from K-Ras. This indicates that Rac is essential for transformation by Ras. In addition, Val-12 Racl synergizes strongly with RafCAAX in focus-formation assays, indicating that oncogenic Ras drives both the Rac and MAP-kinase pathways, which cooperate to cause transformation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ridley, A. J., Paterson, H. F., Johnston, C. L., Diekman, D. & Hall, A. Cell 70, 401–410 (1992).
Gossen, M. & Bujard, H. Proc. natn. Acad. Sci. U.S.A. 89, 5547–5551 (1992).
Gossen, M., Bonin, A. L. & Bujard, H. Trends biochem. Sci. 18, 471–475 (1993).
Paterson, H. F. et al. J. Cell Biol. 111, 1001–1007 (1990).
Cowley, S., Paterson, H., Kemp, P. & Marshall, C. J. Cell 77, 841–852 (1994).
Leevers, S. J., Paterson, H. F. & Marshall, C. J. Nature 369, 411–414 (1994).
Stokoe, D., Macdonald, S. G., Cadwallader, K., Symons, M. & Hancock, J. F. Science 264, 1463–1467 (1994).
Rodriguez-Viciana, P. et al. Nature 370, 527–532 (1994).
Kodaki, T. et al. Curr. Biol. 4, 798–806 (1994).
Hawkins, P. T. et al. Curr. Biol. (in the press).
McGlade, J. et al. EMBO J. 12, 3073–3081 (1993).
Manser, E., Leung, T., Salihuddin, H., Zhao, Z.-s. & Lim, L. Nature 367, 40–46 (1994).
Johnson, G. L. & Vaillancourt, R. R. Curr. Opin. Cell Biol. 6, 230–238 (1994).
Marshall, C. J. Curr. Opin. Genet. Dev. 4, 82–89 (1994).
Cooper, J. A. Curr. Biol. 4, 1118–1120 (1994).
Avraham, H. & Weinberg, R. A. Molec. cell. Biol. 9, 2058–2066 (1989).
Perona, R. et al. Oncogene 8, 1285–1292 (1993).
Self, A. J., Paterson, H. F. & Hall, A. Oncogene 8, 655–661 (1993).
Southern, P. J. & Berg, P. J. molec. appl. Gen. 1, 327–341 (1982).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Qiu, RG., Chen, J., Kirn, D. et al. An essential role for Rac in Ras transformation. Nature 374, 457–459 (1995). https://doi.org/10.1038/374457a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/374457a0
This article is cited by
-
Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies
Signal Transduction and Targeted Therapy (2023)
-
Validation of a small molecule inhibitor of PDE6D-RAS interaction with favorable anti-leukemic effects
Blood Cancer Journal (2022)
-
Akt-mediated Ephexin1–Ras interaction promotes oncogenic Ras signaling and colorectal and lung cancer cell proliferation
Cell Death & Disease (2021)
-
HACE1 blocks HIF1α accumulation under hypoxia in a RAC1 dependent manner
Oncogene (2021)
-
Suppression of RAC1-driven malignant melanoma by group A PAK inhibitors
Oncogene (2018)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
